The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers

The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers

Abstract Introduction Health information technology (HIT) has the potential to improve healthcare delivery and engagement. Studying racial‐ethnic disparities in HIT engagement will help understand and overcome challenges to healthcare utilization. Methods We undertook a patient‐reported survey among...

Full description

Bibliographic Details
Main Authors:	Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Mizba Baksh, Ahsan Rasheed, Saurav Das, Andre J. Fernandez, Aneel Paulus, Asher A. Chanan‐Khan
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Series:	Cancer Medicine
Online Access:	https://doi.org/10.1002/cam4.6454

Similar Items

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
by: Ricardo D. Parrondo, et al.
Published: (2022-04-01)

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
by: Ricardo D. Parrondo, et al.
Published: (2020-01-01)

Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities
by: Sikander Ailawadhi, et al.
Published: (2024-05-01)

Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety
by: Saurav Das, et al.
Published: (2023-10-01)

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
by: Sharad Khurana, et al.
Published: (2019-01-01)

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma
by: Shehzad Niazi, et al.
Published: (2018-05-01)

A Panel Evaluation of the Changes in the General Public’s Social-Media-Following of United States’ Public Health Departments during COVID-19 Pandemic
by: Areej Khokhar, et al.
Published: (2021-03-01)

Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
by: Jarrod Longcor, et al.
Published: (2022-09-01)

Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
by: Ricardo D. Parrondo, et al.
Published: (2024-04-01)

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
by: Aneel Paulus, et al.
Published: (2015-01-01)

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
by: Ricardo D. Parrondo, et al.
Published: (2024-09-01)

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
by: Sikander Ailawadhi, et al.
Published: (2019-10-01)

Extramedullary Solitary Plasmacytoma: Demonstrating the Role of 18F-FDG PET Imaging
by: Archana Gautam, et al.
Published: (2017-04-01)

Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel
by: Rahul Banerjee, et al.
Published: (2024-08-01)

Effect of prednisolone on lung function and bronchodilator responses in stable COPD
by: Chhabra S, et al.
Published: (2006-01-01)

Cardiac Myeloid Sarcoma: Review of Literature
by: Archana Gautam, et al.
Published: (2017-03-01)

Religiosity and Misanthropy across the Racial and Ethnic Divide
by: Rubia R. Valente, et al.
Published: (2023-03-01)

Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma
by: Radhika Bansal, et al.
Published: (2023-04-01)

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
by: Ricardo D. Parrondo, et al.
Published: (2022-06-01)

Global disparities in patients with multiple myeloma: a rapid evidence assessment
by: Maria-Victoria Mateos, et al.
Published: (2023-07-01)

Delayed rise in intracranial pressure in patients with head injury
by: Pankaj Ailawadhi, et al.
Published: (2010-06-01)

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
by: Paul J. Hampel, et al.
Published: (2022-09-01)

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
by: Majid Jaberi-Douraki, et al.
Published: (2024-12-01)

MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis
by: Karan Chohan, et al.
Published: (2023-12-01)

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
by: Sikander Ailawadhi, et al.
Published: (2023-02-01)

Teledermatology for the many, not the few: Tackling the racial health divide in a digital world
by: Jatinder Hayre, et al.
Published: (2021-07-01)

Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA
by: Sikander Ailawadhi, et al.
Published: (2024-01-01)

Whole Exome Sequencing Leading to the Diagnosis of Dysferlinopathy with a Novel Missense Mutation (c.959G>C)
by: Abhisek Swaika, et al.
Published: (2016-01-01)

Immunotherapies in rare cancers
by: Sneha Vivekanandhan, et al.
Published: (2023-02-01)

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
by: Ricardo D. Parrondo, et al.
Published: (2023-10-01)

Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features
by: Bhagirathbhai Dholaria, et al.
Published: (2020-04-01)

Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy
by: Saurabh Zanwar, et al.
Published: (2022-11-01)

Central liponeurocytoma: Case report and review of literature
by: Pankaj Ailawadhi, et al.
Published: (2012-01-01)

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
by: Shebli Atrash, et al.
Published: (2022-03-01)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
by: Huashan Shi, et al.
Published: (2021-12-01)

Little Boxes All the Same? Racial-Ethnic Segregation and Educational Inequality Across the Urban-Suburban Divide
by: Ann Owens, et al.
Published: (2023-02-01)

U.S. regional differences in physical distancing: Evaluating racial and socioeconomic divides during the COVID-19 pandemic.
by: Emma Zang, et al.
Published: (2021-01-01)

Racial Disparities in Surgery
by: Arash Azin, MD, et al.
Published: (2020-12-01)

Iraqui Assyrians in London: beyond the [immigrant /refugee] divide
by: al-Rasheed, M
Published: (1995)

Closing the Racial Wealth Gap: A Counterfactual Historical Simulation of Universal Inheritance
by: Asher Dvir-Djerassi
Published: (2024-06-01)